Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity

Completed

Phase 4 Results N/A

Summary of Purpose

The aim of this clinical study is to investigate the efficacy and safety of Dysport® in patients with early onset of upper limb spasticity within 2-12 weeks after stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 June 2012.

1 Feb 2003 6 Oct 2005 Unavailable 1 Oct 2007 1 Jun 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available